세계의 전임상 이미징 시장 보고서(2025년)

Preclinical imaging encompasses the utilization of various techniques to observe and analyze biological processes within animal models, preceding their application in human clinical trials. These imaging methods enable researchers to monitor disease progression, assess the effectiveness and safety of potential treatments, and acquire deeper insights into the underlying biological mechanisms of diseases.

Key modalities employed in preclinical imaging include optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems involve technologies that leverage light to visualize and capture images of biological tissues, cells, or molecules. They are utilized during the preclinical stage for research purposes, disease diagnosis, monitoring tumor blood vessel growth, and tracking tissue blood oxygenation in animals. This encompasses a spectrum of reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. Hospitals, diagnostic centers, and other entities form the primary user base for these technologies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides preclinical imaging market statistics, including preclinical imaging industry global market size, regional shares, competitors with a preclinical imaging market share, detailed preclinical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. This preclinical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.46 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to government initiatives, the growing prevalence of diseases, expanding applications, increasing awareness, and emerging markets expansion.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, and rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, a rise in R&D activities, collaborations and partnerships, and real-time imaging.

The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. research capabilities by inflating prices of high-resolution micro-CT scanners and Positron Emission Tomography-Magnetic Resonance Imaging systems(PET-MRI systems) manufactured in Japan and Switzerland, resulting in reduced imaging throughput and higher academic lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in chronic diseases is poised to be a significant driver of growth in the preclinical imaging market. Chronic diseases, characterized by prolonged health conditions lasting three months or more, necessitate ongoing medical management and can substantially impact individuals' quality of life. Preclinical imaging tools play a crucial role in identifying these diseases by visualizing bone structure and lung function. Moreover, they contribute to studying chronic diseases, enabling the visualization of disease progression and enhancing overall understanding. For instance, data from the World Health Organization (WHO) 2022 Highlights in September 2022 revealed that 74% of global deaths are caused by Noncommunicable diseases (NCDs) or chronic diseases, amounting to 41 million deaths annually. Notably, this includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is a driving force behind the growth of the preclinical imaging market.

The growing demand for pharmaceutical products is set to propel the expansion of the preclinical imaging market. Pharmaceutical products, encompassing substances formulated to prevent, diagnose, or treat medical conditions, benefit significantly from preclinical imaging in the pharmaceutical industry. This imaging technology enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before progressing to clinical trials. For instance, Eurostat reported in April 2023 that exports of medicinal and pharmaceutical products increased to $307 billion (€287 billion) in 2022, reflecting a 22% rise from the previous year. Concurrently, pharmaceutical product imports increased from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, the Merck Group, a Germany-based pharmaceutical company, reported in February 2023 that pharmaceutical product sales for the year 2022 reached $59.3 billion, marking a 22% increase over the full year 2021. Consequently, the heightened demand for pharmaceutical products emerges as a key driver for the growth of the preclinical imaging market.

Product innovation stands out as a prominent trend gaining traction in the preclinical imaging market, with major companies actively engaged in developing cutting-edge products to maintain their market positions. A notable example is Fujifilm VisualSonics Inc., a Canada-based biomedical company specializing in imaging systems, which introduced Vevo F2 for preclinical imaging in May 2022. Distinguished as the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system, Vevo F2 incorporates HD image processing technology and a novel signal pathway. These features contribute to enhanced image clarity, improved frame rates, and customization options tailored to precision imaging demands. With a broad scope of anatomical targets and high-resolution imaging capabilities, Vevo F2 is well-suited for diverse research applications.

Major players in the preclinical imaging market are intensifying their focus on introducing next-generation imaging systems, positioning themselves strategically to gain a competitive advantage. Next-generation imaging systems represent advanced technologies that surpass current capabilities, integrating cutting-edge features. In a significant development, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems in September 2023, aimed at driving innovation in various preclinical research applications. The product lineup includes the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system seamlessly integrating 2D optical and full 3D imaging. These imaging systems boast enhanced image-based capabilities and are designed to streamline the imaging workflow, marking a significant stride in advancing preclinical imaging technologies.

In February 2024, Bruker Corporation, a US-based medical devices company, acquired Spectral Instruments Imaging (SII) for $37.5 million. This acquisition demonstrates Bruker's commitment to advancing scientific research and enhancing its technological capabilities in the life sciences sector. Spectral Instruments Imaging (SII) is a US-based manufacturer of preclinical optical systems for bioluminescent, fluorescent, and X-ray imaging.

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preclinical Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The preclinical imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
• 2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
• 3) By End User: Hospital; Diagnostics Center; Other End-User
• Subsegments:
• 1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging
• 2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)
• 3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems
• 4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems
• 5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems
• 6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems
• 7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging
• Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Visualsonics Inc.; Konica Minolta Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; Miltenyi Biotech; Sofie Biosciences Inc.; Promega Corporation; Ion Beam Applications S.A; Nihon Kohden; Piramal Enterprises Ltd; LI-COR Biosciences Inc.; Aspect Imaging Ltd; Capintec Inc.; Spectral Instruments Inc.; Mediso Ltd; MR Solutions Ltd; Biospace Lab S. A.; Scintica Instrumentation Inc.; Trifoil Imaging; Bioscan Inc.; CytoSMART Technologies B.V; Inviscan SAS; Kubtec X-ray; MILabs B.V.; SCANCO Medical AG; Cristal Therapeutics.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preclinical Imaging Market Characteristics

3. Preclinical Imaging Market Trends And Strategies

4. Preclinical Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Preclinical Imaging Growth Analysis And Strategic Analysis Framework

• 5.1. Global Preclinical Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Preclinical Imaging Market Growth Rate Analysis
• 5.4. Global Preclinical Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Preclinical Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Preclinical Imaging Total Addressable Market (TAM)

6. Preclinical Imaging Market Segmentation

• 6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-magnetic Resonance Imaging Systems
• Micro-Ultrasound Systems
• Micro-computed Tomography Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
• 6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Optical Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical MRI Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Preclinical CT Contrast Agents
• 6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostics Center
• Other End-User
• 6.4. Global Preclinical Imaging Market, Sub-Segmentation Of Optical Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioluminescence Imaging
• Fluorescence Imaging
• 6.5. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Nuclear Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positron Emission Tomography (PET)
• Single-Photon Emission Computed Tomography (SPECT)
• 6.6. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Magnetic Resonance Imaging (Micro-MRI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Resolution Micro-MRI Systems
• Functional Micro-MRI Systems
• 6.7. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Ultrasound Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Frequency Ultrasound Imaging
• Real-Time Micro-Ultrasound Systems
• 6.8. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Computed Tomography (Micro-CT) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vivo Micro-CT Systems
• Ex Vivo Micro-CT Systems
• 6.9. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Photoacoustic Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Wavelength Photoacoustic Imaging
• Hybrid Photoacoustic Imaging Systems
• 6.10. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Magnetic Particle Imaging (MPI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MPI For Cell Tracking
• MPI For Vascular Imaging

7. Preclinical Imaging Market Regional And Country Analysis

• 7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preclinical Imaging Market

• 8.1. Asia-Pacific Preclinical Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Preclinical Imaging Market

• 9.1. China Preclinical Imaging Market Overview
• 9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Preclinical Imaging Market

• 10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Preclinical Imaging Market

• 11.1. Japan Preclinical Imaging Market Overview
• 11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Preclinical Imaging Market

• 12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Preclinical Imaging Market

• 13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Preclinical Imaging Market

• 14.1. South Korea Preclinical Imaging Market Overview
• 14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Preclinical Imaging Market

• 15.1. Western Europe Preclinical Imaging Market Overview
• 15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Preclinical Imaging Market

• 16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Preclinical Imaging Market

• 17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Preclinical Imaging Market

• 18.1. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Preclinical Imaging Market

• 19.1. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Preclinical Imaging Market

• 20.1. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Preclinical Imaging Market

• 21.1. Eastern Europe Preclinical Imaging Market Overview
• 21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Preclinical Imaging Market

• 22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Preclinical Imaging Market

• 23.1. North America Preclinical Imaging Market Overview
• 23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Preclinical Imaging Market

• 24.1. USA Preclinical Imaging Market Overview
• 24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Preclinical Imaging Market

• 25.1. Canada Preclinical Imaging Market Overview
• 25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Preclinical Imaging Market

• 26.1. South America Preclinical Imaging Market Overview
• 26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Preclinical Imaging Market

• 27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Preclinical Imaging Market

• 28.1. Middle East Preclinical Imaging Market Overview
• 28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Preclinical Imaging Market

• 29.1. Africa Preclinical Imaging Market Overview
• 29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Preclinical Imaging Market Competitive Landscape And Company Profiles

• 30.1. Preclinical Imaging Market Competitive Landscape
• 30.2. Preclinical Imaging Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. FUJIFILM Visualsonics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Preclinical Imaging Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Bruker Corporation
• 31.3. Miltenyi Biotech
• 31.4. Sofie Biosciences Inc.
• 31.5. Promega Corporation
• 31.6. Ion Beam Applications S.A
• 31.7. Nihon Kohden
• 31.8. Piramal Enterprises Ltd
• 31.9. LI-COR Biosciences Inc.
• 31.10. Aspect Imaging Ltd
• 31.11. Capintec Inc.
• 31.12. Spectral Instruments Inc.
• 31.13. Mediso Ltd
• 31.14. MR Solutions Ltd
• 31.15. Biospace Lab S. A.

32. Global Preclinical Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preclinical Imaging Market

34. Recent Developments In The Preclinical Imaging Market

35. Preclinical Imaging Market High Potential Countries, Segments and Strategies

• 35.1 Preclinical Imaging Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Preclinical Imaging Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Preclinical Imaging Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer